Policies and events affecting prescription Opioid use for non-cancer pain among an insured patient population

Pain Physician

Volumn 17, Issue 3, 2014, Pages 205-216

  Ahmedani, Brian K ^a   Peterson, Edward L ^a   Wells, Karen E ^a   Lanfear, David E ^a   Keoki Williams, L ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Adverse drug events; Chronic drug use; Chronic pain; Joint commission; Morphine dose equivalents; Opioid analgesics; Opioid epidemic; Pain management; Prescription drugs; Propoxyphene

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; DIHYDROMORPHINE; FENTANYL; HYDROCODONE; METHADONE; MORPHINE; OXYCODONE; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; DRUG USE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; INFORMATION PROCESSING; LONGITUDINAL STUDY; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PAIN; PRESCRIPTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SAMPLING; UNSPECIFIED SIDE EFFECT; ACCREDITATION; ADULT; CHRONIC PAIN; DRUG UTILIZATION; HEALTH INSURANCE; HUMAN; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HUMANS; INSURANCE, HEALTH; JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS; LONGITUDINAL STUDIES; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84901289098     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Berry PH, Dahl JL. The new JCAHO pain standards: Implications for pain management nurses. Pain Manag Nurs 2000; 1:3-12.
2. Berry PH. Getting ready for JCAHO just meeting the standards or really improving pain management. Clin J Oncol Nurs 2001; 5:110-112.
3. Lanser P, Gesell S. Pain management: The fifth vital sign. Healthc Benchmarks 2001; 8:68-70, 62.
4. Cleeland CS, Reyes-Gibby CC, Schall M, Nolan K, Paice J, Rosenberg JM, Tollett JH, Kerns RD. Rapid improvement in pain management: The Veterans Health Administration and the Institute for Healthcare improvement collaborative. Clin J Pain 2003; 19:298-305.
5. Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000; 284:428-429.
6. Hansen G. Assessment and management of pain. JAMA 2000; 284:2317-2318.
7. Thielke SM, Simoni-Wastila L, Edlund MJ, DeVries A, Martin BC, Braden JB, Fan MY, Sullivan MD. Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med 2010; 11:248-256.
8. Boudreau D, Von KM, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, BantaGreen C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18:1166-1175.
9. Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008; 24:521-527.
10. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008; 299:70-78.
11. IMS Institute for Healthcare Informatics. The Use of Medicines in the United States: Review of 2010. Parsippany, New Jersey, 2011.
12. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363:1981-1985.
13. Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA 2012; 308:1865-1866.
14. Juurlink DN, Dhalla IA. Dependence and addiction during chronic opioid therapy. J Med Toxicol 2012; 8:393-399.
15. Centers for Disease Control and Prevention. CDC grand rounds: Prescription drug overdoses A U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012; 61:10-13.
16. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdoserelated deaths. JAMA 2011; 305:1315-1321.
17. Centers for Disease Control and Prevention. Vital signs: Overdoses of prescription opioid pain relievers United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011; 60:1487-1492.
18. Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, Rand CS, Apter AJ, Lanfear DE, Tunceli K, Pladevall M. Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence. J Allergy Clin Immunol 2007; 120:1153-1159.
19. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 2011; 26:1450-1457.
20. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 2010; 152:85-92.
21. Meier B. A World of Hurt. The New York Times Company, New York, New York, 2013.
22. Van Zee A. The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. Am J Public Health 2009; 99:221-227.
23. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274:1591-1598.
24. Welsfeld V, Miller D, Gibson R, Schroeder SA. Improving care at the end of life: What does it take? Health Aff (Millwood) 2000; 19:277-283.
25. Haugh R. Hospitals and clinicians confront a new imperative: Pain management. Hosp Health Netw 2005; 79:51-56, 52.
26. Social Security Amendments of 1965. http://ssa.gov/OP_Home/ssact/compssa.htm. Accessed January 8, 2014.
27. Medicare Improvements for Patients and Providers Act of 2008. www.gpo.gov/fdsys/pkg/PLAW-110publ275/pdf/PLAW-110publ275.pdf. Accessed January 8, 2014.
28. Sprague L. Hospital oversight in Medicare: Accreditation and deeming authority. NHPF Issue Brief 2005; 802:1-15
29. Brasure M, Stensland J, Wellever A. Quality oversight: Why are rural hospitals less likely to be JCAHO accredited? The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 2000; 16:324-336.
30. Pain Assessment and Management: An Organizational Approach. Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL, 2000.
31. Improving the Quality of Pain Management Through Measurement and Action. Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL, 2003.
32. OxyContin Abuse and Diversion and Efforts to Addrss the Problem. US General Accounting Office. Washington, DC, 2003.
33. Frasco PE, Sprung J, Trentman TL. The impact of the joint commission for accreditation of healthcare organizations pain initiative on perioperative opiate consumption and recovery room length of stay. Anesthesia and Analgesia 2005; 100:162-168.
34. Tormoehlen LM, Mowry JB, Bodle JD, Rusyniak DE. Increased adolescent opioid use and complications reported to a poison control center following the 2000 JCAHO pain initiative. Clinical Toxicology 2011; 49:492-498.
35. Vila H, Jr, Smith RA, Augustyniak MJ, Nagi PA, Soto RG, Ross TW, Cantor AB, Strickland JM, Miguel RV. The efficacy and safety of pain management before and after implementation of hospitalwide pain management standards: Is patient safety compromised by treatment based solely on numerical pain ratings? Anesthesia and Analgesia 2005; 101:474-480, table of contents.
36. Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: A decade of change. J Pain Symptom Manage 2002; 23:138-147.
37. Pain and Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. Second Edition. University of Wisconsin Carbone Cancer Center, Madison, WI, 2003.
38. Pain and Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card. University of Wisconsin Carbone Cancer Center. Madison, WI, 2003.
39. Pain and Policy Studies Group. Achieving Balance in State Pain Policy: A Prog-ress Report Card (CY 2012). University of Wisconsin Carbone Cancer Center. Madison, WI, 2003.
40. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 1986; 25:171-186.
41. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980; 302:123.
42. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995; 274:1874-1880.
43. Department of Veterans Affairs. Pain as the 5th Vital Sign Toolkit. Veterans Health Administration, Washington, D.C., 2000.
44. Public Acts of 1998: An Act to Amend Public Health Code Act 368 of 1978. www.legislature.mi.gov/documents/1997-1998/publicact/pdf/1998PA-0332.pdf. Accessed January 8, 2014.
45. State of Michigan, Bureau of Health Services. Pain and Symptom Management Advisory Committee Report. Lansing, Michigan, 2002.
46. Public Acts of 2001: An Act to Ament Public Health Code Act of 1978. 2002. www.legislature.mi.gov/documents/20012002/publicact/pdf/2001PA-0236.pdf. Accessed January 8, 2014.
47. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006; 174:1589-1594.
48. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010 Jan 20; 1: CD006605.
49. Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: How physicians can help control it. J Clin Psychiatry 2011; 72:589-592.
50. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10:147-159.
51. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Intur-risi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM. Opioid pharmacotherapy for chronicnon-cancer pain in the United States: A research guideline for developing an evidence-base. J Pain 2010; 11:807-829.
52. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain 2008; 24:479-496. 53
53. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 2007; 91:199-211.